Evidence map›Paper›PMID 41908271›Full record

ArticleFrontiers in neurology

Posterior confluent white matter hyperintensities and intracerebral hemorrhage recurrence risk in patients with cerebral amyloid angiopathy.

Jia Liu, Feng Liu, Zihan Wang, Hao Wu, Pan Wang, Hao Lu, Shuai Liu, Shumei Jin, Zhaoyang Lv, Yong Ji and 1 more

Abstract read
In one paragraph

Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jia LiuHuanhu Hospital Affiliated to Tianjin Medical University, Tianjin, China.
Feng LiuHuanhu Hospital Affiliated to Tianjin Medical University, Tianjin, China.
Zihan WangHuanhu Hospital Affiliated to Tianjin Medical University, Tianjin, China.
Hao WuDepartment of Neurology and Tianjin Key Laboratory of Cerebrovascular Disease and Neurodegenerative Disease, Tianjin Dementia Institute, Huanhu Hospital Affiliated to Tianjin Medical University, Tianjin, China.
Pan WangDepartment of Neurology and Tianjin Key Laboratory of Cerebrovascular Disease and Neurodegenerative Disease, Tianjin Dementia Institute, Huanhu Hospital Affiliated to Tianjin Medical University, Tianjin, China.
Hao LuDepartment of Radiology, Huanhu Hospital Affiliated to Tianjin Medical University, Tianjin, China.
Shuai LiuDepartment of Neurology and Tianjin Key Laboratory of Cerebrovascular Disease and Neurodegenerative Disease, Tianjin Dementia Institute, Huanhu Hospital Affiliated to Tianjin Medical University, Tianjin, China.
Shumei JinDepartment of Pathology, Huanhu Hospital Affiliated to Tianjin Medical University, Tianjin, China.
Zhaoyang LvHuanhu Hospital Affiliated to Tianjin Medical University, Tianjin, China.
Yong JiDepartment of Neurology and Tianjin Key Laboratory of Cerebrovascular Disease and Neurodegenerative Disease, Tianjin Dementia Institute, Huanhu Hospital Affiliated to Tianjin Medical University, Tianjin, China.
Zhihong ShiDepartment of Neurology and Tianjin Key Laboratory of Cerebrovascular Disease and Neurodegenerative Disease, Tianjin Dementia Institute, Huanhu Hospital Affiliated to Tianjin Medical University, Tianjin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cerebral amyloid angiopathy (CAA) is associated with a high risk of recurrence of intracerebral hemorrhage (ICH). This study aimed to identify risk factors of CAA-related ICH recurrence, especially focused on CAA-characteristic neuroimaging markers. Methods: Consecutive survivors of spontaneous lobar ICH for probable CAA, possible CAA, and mixed cerebral small vessel disease (CSVD) were enrolled at Tianjin Huanhu Hospital between 2017 and 2024. Baseline clinical data and magnetic resonance imaging (MRI) findings were collected. Posterior confluent white matter hyperintensities (WMH-PC), which means WMHs predominantly posterior to the ventricular horns, extending more than 5 mm in the deep white matter. Other MRI features included multispot white matter hyperintensities (WMH-MS), cortical superficial siderosis (cSS), perivascular spaces (PVS), and acute convexity subarachnoid hemorrhage (cSAH) in the present study. Participants were prospectively followed for recurrent symptomatic ICH or death. Kaplan-Meier and Cox-regression models were used to assess associations with ICH recurrence risk. Results: The cohort included 254 survivors of spontaneous ICH, with median age of 68.5 years (interquartile range [IQR]: 63.0-76.0) and 63.0% male. WMH-PC was present in 124 patients (48.8%). Hundred and seventy patients (66.9%) were probable CAA-related ICH. Over a median follow-up period of 20.0 months (IQR: 8.0-38.0), 53 patients (20.9%) experienced recurrent ICH. In the probable CAA-related ICH group, WMH-PC (adjusted hazard ratio [aHR]: 2.548; 95% confidence interval [CI]: 1.251-5.193); cSS (aHR: 2.340; 95% CI: 1.126-4.860); and CSO-PVS (aHR: 2.751; 95% CI: 1.219-6.207) were associated with increased risk of ICH recurrence; after adjusted for the MRI features, only CSO-PVS (aHR: 2.278; 95% CI: 1.075-4.828) remained independently associated with an increased risk of ICH recurrence. The effect of combined WMH-PC and cSS on the recurrence of ICH in cases of probable CAA was synergistic (aHR: 3.160; 95% CI: 1.579-6.325). Conclusions: WMH-PC, cSS and CSO-PVS are risk factors associated with ICH recurrence and WMH-PC in combination with cSS demonstrates a synergistic effect on increased ICH recurrence risk in patients with probable CAA.

Indexed as

cerebral amyloid angiopathy (CAA)intracerebral hemorrhagemagnetic resonance imagingrecurrentrisk factors

Identifiers

PMID41908271
PMCPMC13021402

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.